Neurocrine Biosciences, Inc.
Methods for the administration of certain VMAT2 inhibitors
Last updated:
Abstract:
Provided are methods of administering a vesicular monoamine transport 2 (VMAT2) inhibitor chosen from valbenazine, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof.
Status:
Grant
Type:
Utility
Filling date:
3 Aug 2020
Issue date:
8 Jun 2021